What will it take to scale up teledermatology? Providers’ perspectives in Kenya and Uganda
Clinical and Experimental Dermatology · 17.09.2026
DOI: 10.1093/ced/llag407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 17.09.2026. Verfasst von Chloe Sales und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, USA. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Allergy, Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Background
A shortage of dermatologists in resource-limited settings often results in patients receiving dermatological management from other providers, who may lack relevant expertise. In East Africa, teledermatology (TD) has recently emerged as a potential solution to improve dermatological care and patient outcomes. In February 2023, TD was implemented at 12 ambulatory HIV clinics in Kenya and Uganda, with variable uptake. We explored barriers to and facilitators of TD uptake among primary care providers in these clinics.
Objectives
To elucidate user perceptions of factors affecting successful TD uptake.
Methods
Between August and November 2024, we conducted focus group discussions (FGDs) among providers (including nurses, clinical officers and physicians) recruited via purposive sampling. FGDs were guided by the Theoretical Domains Framework, coded using an abductive approach and analysed using a thematic framework.
Results
We conducted 6 FGDs across 8 clinics, involving 23 participants in Kenya and 10 in Uganda. We found that TD use was generally influenced by its perceived degree of integration into routine care. This integration was facilitated by viewing TD as a professional duty that created learning opportunities for providers, improved patient care and was supported by clinic leadership and culture. Technological integration was facilitated by factors such as TD software compatibility with providers’ mobile devices. Conversely, TD was perceived as burdensome when poorly integrated into existing workflows. This included a lack of integration into existing electronic medical record (EMR) systems, being unavailable on clinics’ computers and an absence of automated reminders about TD feedback. Participant recommendations included providing professional incentives for TD use, such as continuing medical education credits, and integrating TD into clinics’ EMR systems and devices.
Conclusions
Among primary care providers in Kenya and Uganda, TD use was facilitated by integration into routine care and hindered by technological and structural barriers that increased providers’ workload. The challenges of poor TD integration represented an ‘activation energy’ that could be overcome by drivers of professional obligation, including perceptions of TD as a professional duty. Efforts to increase TD use should target context-specific interventions, provider motivation and technological infrastructure. Future studies should assess patients’ perspectives on TD.
Autor:innen und Institutionen
- University of California, San Francisco, USA.
- Indiana University, Indianapolis, USA.
- University of Washington, Seattle, USA.
- Curtin enAble Institute, Curtin University, Perth, Australia.
- Academic Model Providing Access To Healthcare (AMPATH), Moi Teaching and Referral Hospital, Eldoret, Kenya.
- Infectious Diseases Institute (IDI), Makerere University, Kampala, Uganda.
ORCID-Profile: Chloe Sales, Toby Maurer, Samson Kiprono
Förderung
- National Institute of Allergy
- Infectious Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute on Drug Abuse
- National Cancer Institute
- National Institute of Mental Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Fogarty International Center
Zitieren
APA
Sales, C., Maurer, T., Ahuja, S., Grant, M., Chemtai, L., Lagat, C., Nalubega, J. F., Nansereko, M., Achieng, M., Rotich, E., Odhiambo, P., Musinguzi, P., Kiprono, S., Felker, D., Collier, S., Martin, J., & Semeere, A. (2026). What will it take to scale up teledermatology? Providers’ perspectives in Kenya and Uganda. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag407
Vancouver
Sales C, Maurer T, Ahuja S, Grant M, Chemtai L, Lagat C, et al. What will it take to scale up teledermatology? Providers’ perspectives in Kenya and Uganda. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag407
BibTeX
@article{Sales2026,
author = {Sales, Chloe and Maurer, Toby and Ahuja, Sonya and Grant, Merridy and Chemtai, Linda and Lagat, Celestine and Nalubega, Jane Frances and Nansereko, Martha and Achieng, Marion and Rotich, Elyne and Odhiambo, Philip and Musinguzi, Patrick and Kiprono, Samson and Felker, David and Collier, Sigrid and Martin, Jeffrey and Semeere, Aggrey},
title = {What will it take to scale up teledermatology? Providers’ perspectives in Kenya and Uganda},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag407}
}
EUVIMED